Ting Feng, Ph.D., is a Vice President with Lilly Asia Ventures (LAV). Prior to joining LAV, Ting was a Senior Investment Manager at SAIF Partners, focusing on healthcare investment in China. Prior to SAIF, Ting worked as a Senior Consultant at IMS Consulting Group and postdoctoral fellow at Harvard Medical School. Ting holds a Ph.D. in Immunology from University of Alabama at Birmingham and B.S. in Biotechnology from Wuhan University.